Use of Esketamine Combined with Dexmedetomidine for Difficult Tracheal Intubation in an Uncooperative Pediatric Patient with Severe Trismus: A Case Report

Authors

  • Jue Jiang Department of Anesthesiology, Shanghai 9th People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China, https://ror.org/010826a91 Author https://orcid.org/0009-0001-8283-4038
  • Guifang Yu Department of Anesthesiology, Shanghai 9th People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China, https://ror.org/010826a91 Author https://orcid.org/0009-0009-4289-080X

DOI:

https://doi.org/10.66166/cjaim.2.1.8

Keywords:

General Anesthesia, Head and Neck Neoplasms, Intratracheal Intubation , Trismus, Sedation

Abstract

Managing difficult airways in pediatric patients with severe trismus and poor cooperation is challenging because conventional sedatives may suppress spontaneous respiration. We report a case of a 15-year-old girl (weight 50 kg) with recurrent rhabdomyosarcoma causing severe trismus (0-finger mouth opening) and facial deformity. After premedication with atropine and methylprednisolone, sedation was achieved with a slow infusion of dexmedetomidine (20 μg over 10 minutes) followed by intravenous esketamine (20 mg, 0.4 mg/kg). This regimen preserved spontaneous breathing with oxygen saturation maintained at 99–100% throughout the procedure. Topical anesthesia of the nasopharynx was performed using 2% lidocaine spray (total dose 100 mg, approximately 2 mg/kg) via spray-as-you-go technique. Fiberoptic nasotracheal intubation was then successfully accomplished without coughing, body movement, or hemodynamic instability. No adverse events such as emergence reactions or hallucinations occurred. This multimodal sedation approach may offer a safe and effective alternative when preserving spontaneous respiration is critical in uncooperative pediatric patients with severely restricted mouth opening.

References

1. Frerk C, Mitchell VS, McNarry AF, Mendonca C, Bhagrath R, Patel A, O'Sullivan EP, Woodall NM, Ahmad I; Difficult Airway Society intubation guidelines working group. Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth. 2015 Dec;115(6):827-48. doi: 10.1093/bja/aev371. Epub 2015 Nov 10. PMID: 26556848; PMCID: PMC4650961.

2. Apfelbaum JL, Hagberg CA, Connis RT, Abdelmalak BB, Agarkar M, Dutton RP, Fiadjoe JE, Greif R, Klock PA, Mercier D, Myatra SN, O'Sullivan EP, Rosenblatt WH, Sorbello M, Tung A. 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway. Anesthesiology. 2022 Jan 1;136(1):31-81. doi: 10.1097/ALN.0000000000004002. PMID: 34762729.

3. Heinrich S, Birkholz T, Ihmsen H, Irouschek A, Ackermann A, Schmidt J. Incidence and predictors of difficult laryngoscopy in 11,219 pediatric anesthesia procedures. Paediatr Anaesth. 2012 Aug;22(8):729-36. doi: 10.1111/j.1460-9592.2012.03813.x. Epub 2012 Feb 20. PMID: 22340664.

4. Mion G, Himmelseher S. Esketamine: Less Drowsiness, More Analgesia. Anesth Analg. 2024 Jul 1;139(1):78-91. doi:10.1213/ANE.0000000000006851. Epub 2024 Jan 31. PMID: 38295061.

5. Tang ZH, Chen Q, Wang X, Su N, Xia Z, Wang Y, Ma WH. A systematic review and meta-analysis of the safety and efficacy of remifentanil and dexmedetomidine for awake fiberoptic endoscope intubation. Medicine (Baltimore). 2021 Apr 9;100(14):e25324. doi: 10.1097/MD.0000000000025324. PMID: 33832107; PMCID: PMC8036033.

6. Mason KP, Zurakowski D, Zgleszewski SE, Robson CD, Carrier M, Hickey PR, Dinardo JA. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth. 2008 May;18(5):403-11. doi: 10.1111/j.1460-9592.2008.02468.x. Epub 2008 Mar 18. PMID: 18363626.

7. Bergese SD, Candiotti KA, Bokesch PM, Zura A, Wisemandle W, Bekker AY; AWAKE Study Group. A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. Am J Ther. 2010 Nov-Dec;17(6):586-95. doi: 10.1097/MJT.0b013e3181d69072. PMID: 20535016.

8. Cook TM, Kelly FE. The Difficult Airway Society 2015 guidelines and the sacred cows of routine airway management. Anaesthesia. 2016 Apr;71(4):466-7. doi: 10.1111/anae.13440. PMID: 26994533.

9. Xing F, Zhang TT, Yang Z, Qu M, Shi X, Li Y, Li Y, Zhang W, Wang Z, Xing N. Comparison of dexmedetomidine and a dexmedetomidineesketamine combination for reducing dental anxiety in preschool children undergoing dental treatment under general anesthesia: A randomized controlled trial. J Affect Disord. 2024 Feb 15;347:569-575. doi: 10.1016/j.jad.2023.12.011. Epub 2023 Dec 6. PMID: 38065480.

10. Xu C, Zheng G, Zhuo Y, et al. Intranasal Esketamine Premedication Reduces Sevoflurane Requirements During Laryngeal Mask Airway Insertion in Pediatric Patients: A Randomized Controlled Trial. Drug Des Devel Ther. 2025;19(12):6943-6953.

11. Sun L, Guo R, Sun L. Dexmedetomidine for preventing sevoflurane-related emergence agitation in children: a meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand. 2014 Jul;58(6):642-50. doi: 10.1111/aas.12292. Epub 2014 Mar 3. PMID: 24588393.

Downloads

Published

06-07-2026

Data Availability Statement

no